Type
Offshoring/Delocalisation
Country
Poland
Region
Makroregion północno-zachodni; Wielkopolskie; Miasto Poznań
Location of affected unit(s)
Poznań
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations

501 jobs
Number of planned job losses
Job loss
Announcement Date
23 September 2026
Employment effect (start)
23 September 2026
Foreseen end date

Description

GSK, a British pharmaceutical company, announced in September 2026 the reduction of more than 500 posts at its Poznań site in Wielkopolskie. The company decided to transfer part of the activity to India and to consolidate some support services outside Poland, under a three-year programme presented in July to simplify operations and concentrate resources, supporting a sales target above GBP 40 billion by 2031.

The posts affected are in information technology, a support function within the site, rather than in pharmaceutical production. No timeline for implementing the job losses has been announced. NSZZ Solidarność, whose company organisation is chaired by Hieronim Marut, is entering negotiations on departure terms. GSK states that supporting employees and cooperating with the unions is its priority.

Poznań will remain the location of one of GSK's two multifunctional Global Capability Centres.


Citation

Eurofound (2026), GSK, Offshoring/Delocalisation in Poland, factsheet number 301146, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/301146.